187 related articles for article (PubMed ID: 24102214)
1. Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition.
Ligresti A; Martos J; Wang J; Guida F; Allarà M; Palmieri V; Luongo L; Woodward D; Di Marzo V
Br J Pharmacol; 2014 Mar; 171(6):1408-19. PubMed ID: 24102214
[TBL] [Abstract][Full Text] [Related]
2. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
[TBL] [Abstract][Full Text] [Related]
3. Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris.
Woodward DF; Krauss AH; Wang JW; Protzman CE; Nieves AL; Liang Y; Donde Y; Burk RM; Landsverk K; Struble C
Br J Pharmacol; 2007 Feb; 150(3):342-52. PubMed ID: 17179945
[TBL] [Abstract][Full Text] [Related]
4. Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry.
Weber A; Ni J; Ling KH; Acheampong A; Tang-Liu DD; Burk R; Cravatt BF; Woodward D
J Lipid Res; 2004 Apr; 45(4):757-63. PubMed ID: 14729864
[TBL] [Abstract][Full Text] [Related]
5. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
6. Prostamides (prostaglandin-ethanolamides) and their pharmacology.
Woodward DF; Liang Y; Krauss AH
Br J Pharmacol; 2008 Feb; 153(3):410-9. PubMed ID: 17721551
[TBL] [Abstract][Full Text] [Related]
7. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
8. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
Slivicki RA; Xu Z; Mali SS; Hohmann AG
Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
[TBL] [Abstract][Full Text] [Related]
9. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
[TBL] [Abstract][Full Text] [Related]
10. Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology.
Lamani M; Malamas MS; Farah SI; Shukla VG; Almeida MF; Weerts CM; Anderson J; Wood JT; Farizatto KLG; Bahr BA; Makriyannis A
Bioorg Med Chem; 2019 Dec; 27(23):115096. PubMed ID: 31629610
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
Lichtman AH; Shelton CC; Advani T; Cravatt BF
Pain; 2004 Jun; 109(3):319-327. PubMed ID: 15157693
[TBL] [Abstract][Full Text] [Related]
12. In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.
Ignatowska-Jankowska BM; Ghosh S; Crowe MS; Kinsey SG; Niphakis MJ; Abdullah RA; Tao Q; O' Neal ST; Walentiny DM; Wiley JL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2014 Mar; 171(6):1392-407. PubMed ID: 23848221
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
15. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms.
Maione S; Morera E; Marabese I; Ligresti A; Luongo L; Ortar G; Di Marzo V
Br J Pharmacol; 2008 Nov; 155(5):775-82. PubMed ID: 18660824
[TBL] [Abstract][Full Text] [Related]
17. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V
Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581
[TBL] [Abstract][Full Text] [Related]
18. Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.
Grim TW; Ghosh S; Hsu KL; Cravatt BF; Kinsey SG; Lichtman AH
Pharmacol Biochem Behav; 2014 Sep; 124():405-11. PubMed ID: 25058512
[TBL] [Abstract][Full Text] [Related]
19. Anandamide-derived prostamide F2α negatively regulates adipogenesis.
Silvestri C; Martella A; Poloso NJ; Piscitelli F; Capasso R; Izzo A; Woodward DF; Di Marzo V
J Biol Chem; 2013 Aug; 288(32):23307-21. PubMed ID: 23801328
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism.
Matias I; Chen J; De Petrocellis L; Bisogno T; Ligresti A; Fezza F; Krauss AH; Shi L; Protzman CE; Li C; Liang Y; Nieves AL; Kedzie KM; Burk RM; Di Marzo V; Woodward DF
J Pharmacol Exp Ther; 2004 May; 309(2):745-57. PubMed ID: 14757851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
